Regeneron rose as much as 2.4% in the stock market today, touching a record high of 655.93. Shares seesawed in a small range Thursday before ending the day up a small fraction, at 640.63. The peak price topped Regeneron stock’s previous high of 653.53, touched on Tuesday. Regeneron is part of the IBD Biomed/Biotech group, which ranks No. 14 out of 197 industry groups tracked. The group is just off its all-time high, which it hit on June 23.
Regeneron Pharmaceuticals (REGN) jumped to an all-time high Thursday, its second of the week, as analysts remain bullish on Regeneron stock due to its coronavirus treatment and other businesses.
Comments are closed.